+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Naftopidil (CAS 57149-07-2) Global Market Research Report 2024

  • PDF Icon

    Report

  • 50 Pages
  • November 2024
  • Region: Global
  • Merchant Research and Consulting Ltd
  • ID: 4180978
Description Jump to:
This global report is a result of industry experts’ diligent work on researching the world market of Naftopidil. The report helps to build up a clear view of the market trends and developments, identify major players in the industry, and estimate main downstream sectors.

The Naftopidil global market report's key points:

  • Naftopidil description, applications and related patterns
  • Naftopidil market situation
  • Naftopidil manufacturers and distributors
  • Naftopidil prices
  • Naftopidil end-users
  • Naftopidil downstream industries trends
The first chapter introduces the product (composition, structure, hazards, storage, toxicological & ecological information, etc.).

The second chapter focuses on Naftopidil end-uses. The third chapter summarizes data about manufacturing methods.

The fourth chapter is about the related patents. The fifth chapter deals with Naftopidil market trends and forecast, distinguish Naftopidil manufacturers and suppliers.

The sixth chapter provides Naftopidil prices data.

The seventh chapter analyses Naftopidil downstream markets.


This product will be delivered within 5-7 business days.

Table of Contents

1. NAFTOPIDIL GENERAL INFORMATION
1.1. General information, synonyms
1.2. Composition, chemical structure
1.3. Safety information
1.4. Hazards identification
1.5. Handling and storage
1.6. Toxicological & ecological information
1.7. Transport information

2. NAFTOPIDIL APPLICATIONS

3. NAFTOPIDIL MANUFACTURING METHODS

4. NAFTOPIDIL PATENTS

5. NAFTOPIDIL MARKET WORLDWIDE
5.1. Global Naftopidil market analysis: market constraints, drivers and opportunities
5.2. Manufacturers of Naftopidil
  • Europe
  • Asia
  • North America
  • Etc.
5.3. Suppliers of Naftopidil
  • Europe
  • Asia
  • North America
  • Etc.
5.4. Market forecast

6. NAFTOPIDIL MARKET PRICES
  • Europe
  • Asia
  • North America
7. NAFTOPIDIL END-USE SECTOR

Related Topics

Related Reports

Nortriptyline (CAS 72-69-5) Global Market Research Report 2024 - Product Image

Nortriptyline (CAS 72-69-5) Global Market Research Report 2024

  • Report
  • 50 Pages
  • Global
From
Oxybutynin (CAS 5633-20-5) Global Market Research Report 2024 - Product Image

Oxybutynin (CAS 5633-20-5) Global Market Research Report 2024

  • Report
  • 50 Pages
  • Global
From
Ertapenem Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Ertapenem Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 72 Pages
  • Global
From
Hydroxyzine imine Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Hydroxyzine imine Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 103 Pages
  • Global
From
Ascorbic Acid Market Forecast (2025-2032): Industry Size, Market Share Data, Business Insights, Latest Trends, Opportunities, Competitive Analysis and Demand Outlook Report - Product Image

Ascorbic Acid Market Forecast (2025-2032): Industry Size, Market Share Data, Business Insights, Latest Trends, Opportunities, Competitive Analysis and Demand Outlook Report

  • Report
  • 161 Pages
  • Global
From

About the Naftopidil Market

Naftopidil is a drug used to treat urological disorders, such as benign prostatic hyperplasia (BPH). It is a selective alpha-1A adrenergic receptor antagonist, which works by relaxing the muscles in the prostate and bladder neck, allowing for improved urine flow. It is available in both oral and topical formulations, and is often used in combination with other drugs to treat BPH. Naftopidil is a relatively new drug, having been approved by the FDA in the United States in 2018. It is currently approved in several countries, including Japan, South Korea, and Taiwan. It is also being studied for its potential use in other urological disorders, such as overactive bladder. The market for Naftopidil is growing, as it is becoming increasingly recognized as an effective treatment for BPH. It is also becoming more widely available, with more countries approving its use. Some companies in the Naftopidil market include Kissei Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company, Ltd., and Daiichi Sankyo Company, Ltd. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.